Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether D-fagomine affects glycaemic responses to sucrose (commercial white sugar)and quantify the response


Clinical Trial Description

This is a two treatment randomized double-blind crossover study, with each test product replicated twice. Randomization: Subjects will be randomized to a Williams Latin square design balanced for treatment order. Washout: 2 days or more (may return on day 3) Run-in: High carbohydrate diet guidance (>150 g/d) 1 day before treatment, recommend same sized dinner the previous night (no food record collection required) Drop-outs: Subjects who have dropped out before visit 2 will be replaced by another subject randomized in their place (the new subject will complete all treatments) Subjects will report after an overnight (12 hour) fast for baseline sample collection, and will consume the test product in a fasted state. ;


Study Design


Related Conditions & MeSH terms

  • Reduction of Post-prandial Glycaemic Response

NCT number NCT01811303
Study type Interventional
Source Bioglane
Contact
Status Completed
Phase N/A
Start date September 2012
Completion date March 2013